ArticleCureus2026
A Prospective, Randomized Comparative Study of Intravenous and Perineural Dexamethasone as an Adjuvant to Levobupivacaine in Ultrasound-Guided Supraclavicular Brachial Plexus Block for Adult Patients Undergoing Elective Upper Limb Surgery.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Ultrasound-guided supraclavicular brachial plexus block is a widely used regional anesthesia technique for upper limb surgeries, offering effective intraoperative and postoperative analgesia. Dexamethasone, a corticosteroid with analgesic and anti-inflammatory properties, is often used as an adjuvant via either the perineural or the intravenous route to prolong block duration. This study aimed to compare the efficacy of intravenous versus perineural dexamethasone as adjuvants to levobupivacaine in ultrasound-guided supraclavicular blocks. Methods A prospective, randomized, double-blind study was conducted at Sardar Vallabh Bhai Patel Hospital, Meerut, over 18 months. Sixty American Society of Anesthesiologists (ASA) I/II adult patients aged 18-60 years undergoing elective upper limb surgeries were randomly allocated into two equal groups. Group A received 19 mL of 0.5% levobupivacaine with 1 mL of normal saline perineurally and 4 mg (1 mL) of intravenous dexamethasone. Group B received 19 mL of 0.5% levobupivacaine with 4 mg (1 mL) of perineural dexamethasone and 1 mL of intravenous saline. Block performance and drug preparation were done under sterile conditions using ultrasound guidance. Primary outcomes included onset and duration of sensory and motor block. Secondary outcomes were postoperative analgesia duration, hemodynamic changes, pain scores, and complications. Results Perineural dexamethasone (Group B) resulted in significantly faster onset and longer duration of sensory and motor block compared to intravenous administration (Group A) (p < 0.05). The duration of postoperative analgesia was also significantly prolonged in Group B. Hemodynamic parameters remained stable in both groups, and no serious complications were observed. Conclusion Perineural dexamethasone is more effective than intravenous dexamethasone in enhancing the onset and duration of levobupivacaine-induced supraclavicular brachial plexus block. It also provides superior postoperative analgesia without increasing adverse effects. It is recommended as the preferred route for dexamethasone administration in upper limb surgeries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.